Cargando…
In vitro anticancer drug test: A new method emerges from the model of glioma stem cells
Glioblastoma multiforme (GBM) is a grade IV astrocytoma and the most common malignant brain tumor. Current therapies provide a median survival of 12–15 months after diagnosis, due to the high recurrence rate. The failure of current therapies may be due to the presence, within the tumor, of cells cha...
Autores principales: | Riva, Gabriele, Baronchelli, Simona, Paoletta, Laura, Butta, Valentina, Biunno, Ida, Lavitrano, Marialuisa, Dalprà, Leda, Bentivegna, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598297/ https://www.ncbi.nlm.nih.gov/pubmed/28962238 http://dx.doi.org/10.1016/j.toxrep.2014.05.005 |
Ejemplares similares
-
Delineating the Cytogenomic and Epigenomic Landscapes of Glioma Stem Cell Lines
por: Baronchelli, Simona, et al.
Publicado: (2013) -
Resveratrol Impairs Glioma Stem Cells Proliferation and Motility by Modulating the Wnt Signaling Pathway
por: Cilibrasi, Chiara, et al.
Publicado: (2017) -
Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation
por: Riva, Gabriele, et al.
Publicado: (2018) -
DNA Methylation Changes during In Vitro Propagation of Human Mesenchymal Stem Cells: Implications for Their Genomic Stability?
por: Bentivegna, Angela, et al.
Publicado: (2013) -
From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells
por: Redaelli, Serena, et al.
Publicado: (2012)